Cervical and Anal Cancer Screening
- Clinicians should perform cervical and anal cytologic screening for individuals with HIV, regardless of their human papillomavirus (HPV) vaccination status, as recommended in the NYSDOH AI guidelines Screening for Cervical Dysplasia and Cancer in Adults With HIV and Screening for Anal Dysplasia and Cancer in Adults With HIV. (A3)
- Clinicians should examine the neovagina in transgender women who have undergone vaginoplasty to assess for visible HPV lesions at baseline and during the annual comprehensive physical examination; examination can be done using an anoscope, a small vaginal speculum, or a nasal speculum. (A3)
- At each routine monitoring visit, clinicians should ask all patients about sexual behaviors and new sex partners to assess for risk behaviors that require repeat or ongoing screening. (A3)
